Literature DB >> 19786559

The enteropathogenic Escherichia coli effector Cif induces delayed apoptosis in epithelial cells.

Ascel Samba-Louaka1, Jean-Philippe Nougayrède, Claude Watrin, Eric Oswald, Frédéric Taieb.   

Abstract

The cycle inhibiting factor (Cif) belongs to a family of bacterial toxins, the cyclomodulins, which modulate the host cell cycle. Upon injection into the host cell by the type III secretion system of enteropathogenic Escherichia coli (EPEC), Cif induces both G(2) and G(1) cell cycle arrests. The cell cycle arrests correlate with the accumulation of p21(waf1) and p27(kip1) proteins that inhibit CDK-cyclin complexes, whose activation is required for G(1)/S and G(2)/M transitions. Increases of p21 and p27 levels are independent of p53 transcriptional induction and result from protein stabilization through inhibition of the ubiquitin/proteasome degradation pathway. In this study, we show that Cif not only induces cell cycle arrest but also eventually provokes a delayed cell death. Indeed, 48 h after infection with EPEC expressing Cif, cultured IEC-6 intestinal cells were positive for extracellular binding of annexin V and exhibited high levels of cleaved caspase-3 and lactate dehydrogenase release, indicating evidence of apoptosis. Cif was necessary and sufficient for inducing this late apoptosis, and the cysteine residue of the catalytic site was required for Cif activity. These results highlight a more complex role of Cif than previously thought, as a cyclomodulin but also as an apoptosis inducer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19786559      PMCID: PMC2786488          DOI: 10.1128/IAI.00860-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Role of EspF in host cell death induced by enteropathogenic Escherichia coli.

Authors:  J K Crane; B P McNamara; M S Donnenberg
Journal:  Cell Microbiol       Date:  2001-04       Impact factor: 3.715

2.  Induction of epithelial cell death including apoptosis by enteropathogenic Escherichia coli expressing bundle-forming pili.

Authors:  M Abul-Milh; Y Wu; B Lau; C A Lingwood; D Barnett Foster
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

3.  Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli effector Cif, using TEM-1 beta-lactamase as a new fluorescence-based reporter.

Authors:  Xavier Charpentier; Eric Oswald
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

Review 4.  The role of the cyclin-dependent kinase inhibitor p21 in apoptosis.

Authors:  Andrei L Gartel; Angela L Tyner
Journal:  Mol Cancer Ther       Date:  2002-06       Impact factor: 6.261

5.  Adhesion of enteropathogenic Escherichia coli to human intestinal enterocytes and cultured human intestinal mucosa.

Authors:  S Knutton; D R Lloyd; A S McNeish
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

6.  Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition.

Authors:  Olivier Marchès; Terence Neil Ledger; Michèle Boury; Masaru Ohara; Xuanlin Tu; Frédéric Goffaux; Jacques Mainil; Ilan Rosenshine; Motoyuki Sugai; Jean De Rycke; Eric Oswald
Journal:  Mol Microbiol       Date:  2003-12       Impact factor: 3.501

7.  A beta-lactone related to lactacystin induces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcoma cell line.

Authors:  G Fenteany; R F Standaert; G A Reichard; E J Corey; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

8.  Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway.

Authors:  Jean-Philippe Nougayrède; Michael S Donnenberg
Journal:  Cell Microbiol       Date:  2004-11       Impact factor: 3.715

9.  Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli.

Authors:  S Knutton; T Baldwin; P H Williams; A S McNeish
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

10.  Crystal structures of Cif from bacterial pathogens Photorhabdus luminescens and Burkholderia pseudomallei.

Authors:  Allister Crow; Paul R Race; Grégory Jubelin; Carolina Varela Chavez; Jean-Michel Escoubas; Eric Oswald; Mark J Banfield
Journal:  PLoS One       Date:  2009-05-18       Impact factor: 3.240

View more
  25 in total

1.  The type III system-secreted effector EspZ localizes to host mitochondria and interacts with the translocase of inner mitochondrial membrane 17b.

Authors:  Stephanie R Shames; Matthew A Croxen; Wanyin Deng; B Brett Finlay
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

2.  The cyclomodulin cycle inhibiting factor (CIF) alters cullin neddylation dynamics.

Authors:  Tasha B Toro; Julia I Toth; Matthew D Petroski
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

3.  Delivery of antibodies to the cytosol: debunking the myths.

Authors:  Andrea L J Marschall; Congcong Zhang; André Frenzel; Thomas Schirrmann; Michael Hust; Franck Perez; Stefan Dübel
Journal:  MAbs       Date:  2014-05-21       Impact factor: 5.857

4.  Enteropathogenic Escherichia coli dynamically regulates EGFR signaling in intestinal epithelial cells.

Authors:  Jennifer Lising Roxas; Katheryn Ryan; Gayatri Vedantam; V K Viswanathan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-06-05       Impact factor: 4.052

Review 5.  Infection strategies of enteric pathogenic Escherichia coli.

Authors:  Abigail Clements; Joanna C Young; Nicholas Constantinou; Gad Frankel
Journal:  Gut Microbes       Date:  2012-03-01

Review 6.  The struggle within: microbial influences on colorectal cancer.

Authors:  Janelle C Arthur; Christian Jobin
Journal:  Inflamm Bowel Dis       Date:  2011-01       Impact factor: 5.325

Review 7.  Which bacterial toxins are worthy of validation as markers in colorectal cancer screening? A critical review.

Authors:  Kristyna Mezerova; Vladislav Raclavsky; Lubomir Stary
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2021-11-05       Impact factor: 1.245

Review 8.  Molecular mechanisms of Escherichia coli pathogenicity.

Authors:  Matthew A Croxen; B Brett Finlay
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

Review 9.  Bacterial oncogenesis in the colon.

Authors:  Christine Dejea; Elizabeth Wick; Cynthia L Sears
Journal:  Future Microbiol       Date:  2013-04       Impact factor: 3.165

10.  Rifaximin-mediated changes to the epithelial cell proteome: 2-D gel analysis.

Authors:  Caroline Schrodt; Erin E McHugh; Mary Ann Gawinowicz; Herbert L Dupont; Eric L Brown
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.